Abstract
A new HPLC method have been developed and validated for simultaneous determination of carprofen, vitamin B1, B6 and B12 in veterinary pharmaceutical preparations medicines. The method used a Hypersil GOLD aQ (250 x 4.6 mm, 5 µm) column, under the following chromatographic conditions: gradient elution, using a mobile phase composed by phosphate buffer (pH 2.65) and methanol as an organic modifier. The mobile phase was delivered at a flow rate of 1 mL/min and the detection was made by photodiode array (PDA) detector at 292 nm. This method was fully validated and applied on available pharmaceutical product. The limit of detection (LOD) and limit of quantitation (LOQ) for vitamin B1 were 0.5ng/mL and 1.5ng/mL respectively while for vitamin B12 were 1ng/mL and 5ng/mL respectively The main advantages of this HPLC method relies on the possibility to asses in a single run all the above mentioned drugs.
Keywords: Carprofen, vitamin B1, B6 and B12, HPLC, pharmaceutical analysis
Current Analytical Chemistry
Title:Determination of Carprofen in the Presence of some Hydrosoluble Vitamins of Group B by HPLC Method
Volume: 11 Issue: 4
Author(s): Georgeta-Simona Stan, Bianca Elena Mitoi, Andrei Mihaila, Irinel Adriana Badea and Hassan Y. Aboul-Enein
Affiliation:
Keywords: Carprofen, vitamin B1, B6 and B12, HPLC, pharmaceutical analysis
Abstract: A new HPLC method have been developed and validated for simultaneous determination of carprofen, vitamin B1, B6 and B12 in veterinary pharmaceutical preparations medicines. The method used a Hypersil GOLD aQ (250 x 4.6 mm, 5 µm) column, under the following chromatographic conditions: gradient elution, using a mobile phase composed by phosphate buffer (pH 2.65) and methanol as an organic modifier. The mobile phase was delivered at a flow rate of 1 mL/min and the detection was made by photodiode array (PDA) detector at 292 nm. This method was fully validated and applied on available pharmaceutical product. The limit of detection (LOD) and limit of quantitation (LOQ) for vitamin B1 were 0.5ng/mL and 1.5ng/mL respectively while for vitamin B12 were 1ng/mL and 5ng/mL respectively The main advantages of this HPLC method relies on the possibility to asses in a single run all the above mentioned drugs.
Export Options
About this article
Cite this article as:
Stan Georgeta-Simona, Mitoi Elena Bianca, Mihaila Andrei, Badea Adriana Irinel and Aboul-Enein Y. Hassan, Determination of Carprofen in the Presence of some Hydrosoluble Vitamins of Group B by HPLC Method, Current Analytical Chemistry 2015; 11 (4) . https://dx.doi.org/10.2174/1573411011666150326001707
DOI https://dx.doi.org/10.2174/1573411011666150326001707 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Runx1/AML1 is a Guardian of Hematopoietic Stem Cells
Current Cancer Therapy Reviews Chemokines and Brain Functions
Current Drug Targets - Inflammation & Allergy The Significance of The Detection of Serum Lactate Dehydrogenase, Hypersensitive C-Reactive Protein, and N-Terminal Pro-Brain Natriuretic Peptide for the Evaluation of the Severity and Progression of Pediatric Patients with Traumatic Brain Injury
Current Neurovascular Research Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells
Current Cancer Drug Targets Anti-Adhesion Molecules: is Gut Specificity the Key for a Good Safety Profile?
Current Drug Delivery Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
Current Nanoscience Patent Selections
Recent Patents on Biotechnology Microglial Activation and its Implications in the Brain Diseases
Current Medicinal Chemistry Insulin, Thrombin, ERK1/2 Kinase and Vascular Smooth Muscle Cells Proliferation
Current Pharmaceutical Design Intracellular Logistics of BST-2/Tetherin
Current HIV Research Hepatocytes as Cytotoxic Effector Cells
Current Immunology Reviews (Discontinued) Perspectives of Engineered Marine Derived Polymers for Biomedical Nanoparticles
Current Pharmaceutical Design Comparison of the Efficacy of HIV-1 Nef-Tat-Gp160-p24 Polyepitope Vaccine Candidate with Nef Protein in Different Immunization Strategies
Current Drug Delivery Fighting with the Enemys Weapons? The Role of Costimulatory Molecules in HIV
Current Molecular Medicine Designing Proteins That Work Using Recombinant Technologies
Current Pharmaceutical Biotechnology Quantitative Structure Activity Relationships in Drug Metabolism
Current Topics in Medicinal Chemistry Oxidative Stress and Cancer: The Role of Nrf2
Current Cancer Drug Targets P2Y Receptor Activation Affects the Proliferation and Differentiation of Glial and Neuronal Cells: A Focus on Rat C6 Glioma Cells
Current Neuropharmacology Immunotherapy for Epithelial Ovarian Cancer - Immunological Background, Critical Review of Methods and Future Perspectives
Current Immunology Reviews (Discontinued) Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis
Current Pharmaceutical Design